The Case ∣ Allograft dysfunction in a patient with sickle cell disease  by O'Rourke, Edward J. et al.
Kidney International (2008) 74, 1219–1220; doi:10.1038/ki.2008.387
The Case | Allograft dysfunction in a patient with
sickle cell disease
Edward J. O’Rourke1, Christopher M. Laing2, Aakif U. Khan1, R. Hussain1, Richard A. Standish3, John R. Buscombe1,
Andrew J.W. Hilson1 and Mark Harber2
1Department of Nuclear Medicine, Royal Free Hospital, London, UK; 2Department of Renal Medicine, Royal Free Hospital, London, UK and
3Department of Histopathology, Royal Free Hospital, London, UK
Correspondence: Edward J. O’Rourke, Department of Nuclear Medicine, Royal Free Hospital, London NW3 2QG, UK.
E-mail: edwardorourke@bigpond.com
A 33-year-old woman of African origin received a live related
donor allograft. She had end-stage renal disease secondary to
lupus nephritis and was undergoing hemodialysis and had a
background of sickle cell disease. She underwent uncompli-
cated transplant surgery with immediate graft function and a
baseline creatinine level of 0.79 mg/100 ml. Four months after
transplantation she presented with a rise in serum creatinine
to 1.92 mg/100 ml. Duplex ultrasound showed a patent renal
artery and vein and no features of obstruction. There was
reduced vascularity within the renal cortex, and shunting of
capsular vessels into the peripheral renal cortex, with loss
of corticomedullary differentiation. Tc-99m MAG-3 renal
scan (Figure 1) was performed, followed by renal biopsy
(Figure 2).
What is the cause of this abnormal MAG-3 renogram?
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Figure 1 | Tc99m MAG-3 renograms immediately after transplant (left) and at
presentation with acute allograft dysfunction (right).
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The Diagnosis | Acute renal allograft sickling
Tc-99m MAG-3 renogram showed patchy impairment of
perfusion, which contrasted dramatically with the uniform
uptake noted on the renogram performed early in the
postoperative period (Figure 1). Percutaneous renal biopsy
showed focal cortical necrosis and acute tubular damage
consistent with ischemia. Some glomeruli contained
clumped, probably sickled red cells (Figure 2). There were
no features of rejection. Magnetic resonance angiography
demonstrated wedge-shaped areas of infarction in segmental
artery territories with normal major vessels (Figure 3).
Allograft function has remained stable but significantly
impaired.
Chatterjee et al. described a similar case in a male patient
with known sickle cell trait (hemoglobin AS). Following what
appeared clinically to be an episode of acute rejection
resulting in graft loss, histological examination demonstrated
extensive intravascular erythrocyte sickling.1 In one series of
patients with sickle cell disease or trait undergoing renal
transplantation there was a high incidence of crises in the
first year, with a worse-than-expected 1-year graft survival at
67%.2 A further study has shown comparable short-term
outcomes, but reduced long-term graft survival.3 In renal
transplant recipients with sickle cell disease, allograft sickling
should be considered as a potential cause of an acute decline
in function.
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Figure 2 | Cortical renal transplant biopsy stained
with hematoxylin and eosin (original
magnification  40).
Figure 3 | Arterial phase gadolinium enhanced MRA showing
patchy peripheral uptake and wedge shaped hypoperfusion.
No major vessel occlusions were demonstrated.
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